|Bid||33.49 x 4500|
|Ask||33.50 x 8300|
|Day's Range||33.39 - 33.70|
|52 Week Range||29.83 - 37.39|
|PE Ratio (TTM)||28.12|
|Dividend & Yield||1.28 (3.84%)|
|1y Target Est||N/A|
Citigroup on Thursday initiated coverage of electric car maker Tesla at neutral/high risk. Analysts also upgraded PC and printer maker HP and athletic apparel vendor Nike.
Shares of Pfizer (PFE) have gained 5.1% since closing at $32 on June 7, and the stock even looks like it had been making a run for the top of its recent range. In fact, they call themselves "long-time supporters" of the company, and see "opportunities for upside over the long term." So why are they downgrading Pfizer?
Credit Suisse believes Pfizer will suffer from the patent expirations of its key drugs such as Viagra and Lyrica.